Five scientists have won prestigious research awards for developing a life-saving leukemia treatment and for advances in "reprogramming" DNA, which led to a new kind of stem cell. The $250,000 Lasker Awards will be presented Oct. 2 in New York by the Albert and Mary Lasker Foundation ...

Drug maker Novartis AG posted a 10 percent drop in second quarter net profit Thursday because of shifts in currency values and higher financing costs that detracted from a strong performance by the pharmaceuticals division. The profit of $2 billion was down from $2.3 billion in the same period of 2008. Sales similarly declined because of fluctuating currency rates ...

NOVARTIS: RADICALLY REMAKING ITS DRUG BUSINESS

Five neuroscientists file nervously into Novartis' vast boardroom in Basel. CEO Daniel L. Vasella is seated at the table, along with nine senior executives that make up the company's innovation board. The scientists hope to persuade Vasella to move forward on an experimental vaccine for Alzheimer's disease, an illness that afflicts 25 ...

Pharmaceuticals maker Novartis AG reported Thursday a 14 percent decline in first-quarter net profit in part due to shifts in currency values as well as the cost of financing its takeover of the Alcon eye care company. Novartis said the profit of $1.98 billion compared with $2.3 ...